ESR1 and breast carcinoma: Triple negative breast cancer is characterized as being estrogen receptor, progesterone receptor and HER-2/neu receptor negative; it is a heterogeneous breast cancer subtype that is difficult to treat and is associated with high recurrence and poor outcome [1].